Roles of natural killer cells in immunity to cancer, and applications to immunotherapy

NK Wolf, DU Kissiov, DH Raulet - Nature Reviews Immunology, 2023 - nature.com
Great strides have been made in recent years towards understanding the roles of natural
killer (NK) cells in immunity to tumours and viruses. NK cells are cytotoxic innate lymphoid …

Natural killer cells: development, maturation, and clinical utilization

AM Abel, C Yang, MS Thakar… - Frontiers in …, 2018 - frontiersin.org
Natural killer (NK) cells are the predominant innate lymphocyte subsets that mediate anti-
tumor and anti-viral responses, and therefore possess promising clinical utilization. NK cells …

A vaccine targeting resistant tumours by dual T cell plus NK cell attack

S Badrinath, MO Dellacherie, A Li, S Zheng, X Zhang… - Nature, 2022 - nature.com
Most cancer vaccines target peptide antigens, necessitating personalization owing to the
vast inter-individual diversity in major histocompatibility complex (MHC) molecules that …

The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy

S Paul, G Lal - Frontiers in immunology, 2017 - frontiersin.org
Natural killer (NK) cells are innate immune cells that show strong cytolytic function against
physiologically stressed cells such as tumor cells and virus-infected cells. NK cells show a …

NKG2D receptor and its ligands in host defense

LL Lanier - Cancer immunology research, 2015 - AACR
NKG2D is an activating receptor expressed on the surface of natural killer (NK) cells, CD8+
T cells, and subsets of CD4+ T cells, invariant NKT cells (iNKT), and γδ T cells. In humans …

Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma

JH Lee, YS Lim, Y JE, TJ Song, GY Gwak… - …, 2015 - scholarx.skku.edu
Background & Aims No adjuvant therapy has been shown to extend the survival of patients
with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether …

[HTML][HTML] STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2Dhi CD8+ T cell dysregulation and accumulation

E Masle-Farquhar, KJL Jackson, TJ Peters, G Al-Eryani… - Immunity, 2022 - cell.com
The association between cancer and autoimmune disease is unexplained, exemplified by T
cell large granular lymphocytic leukemia (T-LGL) where gain-of-function (GOF) somatic …

NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists

CJ Nicolai, N Wolf, IC Chang, G Kirn, A Marcus… - Science …, 2020 - science.org
Several immunotherapy approaches that mobilize CD8+ T cell responses stimulate tumor
rejection, and some, such as checkpoint blockade, have been approved for several cancer …

Targeting natural killer cells and natural killer T cells in cancer

E Vivier, S Ugolini, D Blaise, C Chabannon… - Nature Reviews …, 2012 - nature.com
Natural killer (NK) cells and natural killer T (NKT) cells are subsets of lymphocytes that share
some phenotypical and functional similarities. Both cell types can rapidly respond to the …

Regulation of ligands for the NKG2D activating receptor

DH Raulet, S Gasser, BG Gowen… - Annual review of …, 2013 - annualreviews.org
NKG2D is an activating receptor expressed by all NK cells and subsets of T cells. It serves
as a major recognition receptor for detection and elimination of transformed and infected …